Radiation Dose Management - Global Market Outlook (2017-2026)

Publishing Date : 18 May 2018 Report Code : MRC_1138 Pages : 171 Category : Healthcare and Pharma

"According to Stratistics MRC, the Global Radiation Dose Management Market is accounted for $150.36 million in 2017 and is expected to reach $3256.34 million by 2026 growing at a CAGR of 40.7% during the forecast period. Rising awareness and industry initiatives for radiation dose management, growing concerns over radiation overexposure and increasing focus on improving quality of patient care are some of the key driving factors for the market growth. However, lack of reimbursement for accepting radiation dose management solutions and low implementation of Rdm solutions in emerging countries are some of the factors hindering the market growth. Moreover, rising focus on interventional radiology and nuclear medicine and technological advancements provides ample opportunities for the market growth. By products and services, services section is predicted to lead the market and is likely to continue its dominance during the forecast period owing to the software helping to build robust radiation safety program and helps in collecting and storing dose data within the patient’s clinical record. The services section is subdivided into consulting services, support and maintenance services, education and training services and implementation and integration services. By geography, North America is having the largest market share and is dominating the global market owing to rising risks and incidences of constant disorders, strict rules towards the patient's security and care. Europe is the highest growing market owing to rising patient safety and the need to improve overall efficiency in healthcare organizations are driving the growth of the market. Some of the key players profiled in the Radiation Dose Management Market include GE Healthcare Ltd., Koninklijke Philips N.V., Sectra Medical Systems GmbH, Toshiba Medical Systems Corporation, AGFA HealthCare, PACS Health LLC, Fujifilm Holdings Corporation, Novarad Corporation, Bayer AG, Siemens Healthcare Diagnostics Inc., Mckesson Corporation, Medsquare, Bracco Imaging S.P.A., Qaelum N.V. and Landauer, Inc. Modalities Covered: Radiography and Mammography Nuclear medicine scans Computed Tomography Fluoroscopy and interventional imaging Other Modalities Product and Services Covered: Software Services Applications Covered: Cardiology Orthopedic Oncology Other Applications End Users Covered: Ambulatory Care Settings Research Organizations and Academic Medical Centers Hospitals and clinics Diagnostic centers Regions Covered: North America o US o Canada o Mexico Europe o Germany o UK o Italy o France o Spain o Rest of Europe Asia Pacific o Japan o China o India o Australia o New Zealand o South Korea o Rest of Asia Pacific South America o Argentina o Brazil o Chile o Rest of South America Middle East & Africa o Saudi Arabia o UAE o Qatar o South Africa o Rest of Middle East & Africa What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements "

Table of Figures